With 1.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.28 million shares. During the session, the Personal Services company that operates in wider Consumer Cyclical sector, reached to the highest price of $0.6151 whereas the lowest price it dropped to was $0.43. The 52-week range on MRM shows that it touched its highest point at $8.39 and its lowest point at $0.34 during that stretch. It currently has a 1-year price target of $5.00. Beta for the stock currently stands at 0.24.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRM was up-trending over the past week, with a rise of 43.78%, but this was down by -23.88% over a month. Three-month performance dropped to -48.75% while six-month performance fell -80.76%. The stock lost -91.37% in the past year, while it has lost -49.75% so far this year.
Float and Shares Shorts:
On 2025-03-14, short shares totaled 0.25 million, which was 314.00003 higher than short shares on 1739491200. In addition to Mr. Kouji Eguchi as the firm’s CEO & Representative Director, Mr. Akira Aoki serves as its Executive Officer & Chief Medical Officer.
Institutional Ownership:
Through their ownership of 0.033180002 of MRM’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MRM analysts setting a high price target of 5.2938485 and a low target of 5.2938485, the average target price over the next 12 months is 5.2938485. Based on these targets, MRM could surge 918.05% to reach the target high and rise by 918.05% to reach the target low. Reaching the average price target will result in a growth of 918.05% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $10.85453 being high and $10.85453 being low. For MRM, this leads to a yearly average estimate of $10.85453. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
